(Q33364906)

26 July 2017

Endogenous leukemia inhibitory factor attenuates endotoxin response (English)

1 reference

26 July 2017

1 reference

1 reference

Silvia Schnyder-Candrian

2

object named as

Silvia Schnyder-Candrian

0 references

Bernhard Ryffel

7

object named as

Bernhard Ryffel

0 references

Valeria Poli

object named as

Valeria Poli

5

0 references

author name string

Marietta A Weber

1

1 reference

26 July 2017

Bruno Schnyder

3

1 reference

26 July 2017

Valerie Quesniaux

4

1 reference

26 July 2017

Colin L Stewart

6

1 reference

26 July 2017

1 February 2005

1 reference

26 July 2017

Laboratory Investigation

1 reference

26 July 2017

85

1 reference

26 July 2017

276-284

1 reference

26 July 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.3700216

26 July 2017

0 references

cites work

The leukemia inhibitory factor (LIF)

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

LIF: lots of interesting functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

D-factor/leukaemia inhibitory factor: evidence for its role as a mediator in acute and chronic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Leukemia inhibitory factor, Interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

LIF: a molecule with divergent actions on myeloid leukaemic cells and embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Studies using leukemia inhibitory factor (LIF) knockout mice and a LIF adenoviral vector demonstrate a key anti-inflammatory role for this cytokine in cutaneous inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Galactosamine-induced sensitization to the lethal effects of endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

The acute-phase response protects mice from D-galactosamine sensitization to endotoxin and tumor necrosis factor–α

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Interferon gamma receptor deficient mice are resistant to endotoxic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Experimental hepatitis induced by D-galactosamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Protection by alpha 1-acid glycoprotein against tumor necrosis factor-induced lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Human recombinant interleukin-1 alpha protection against the lethality of endotoxin and experimental sepsis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Role of acute-phase proteins in interleukin-1-induced nonspecific resistance to bacterial infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Defective inflammatory response in interleukin 6-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

Circulating leukemia inhibitory factor levels correlate with disease severity in meningococcemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

7 January 2021

Endogenous D-factor activity partially mediates the toxic but not the therapeutic effects of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

7 January 2021

Interleukin-10 production during septicaemia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

7 January 2021

Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

7 January 2021

Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

7 January 2021

In vivo evidence for protease-catalysed mechanism providing bioactive tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700216

7 January 2021

10.1038/LABINVEST.3700216

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference